Section 3 Minimum requirements for the quality systems for the performance of pharmacovigilance activities by national competent authorities and the AgencyF1
United Kingdom
- 14Management of human resources
- 15Compliance management
- 16Record management and data retention
- 17Audit
Annotations
Textual amendments
- F1
Regulation revoked in part (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(t) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)